Close

Piper Jaffray Maintains Underweight, $0.10 PT on MannKind (MNKD) Post Q2

Go back to Piper Jaffray Maintains Underweight, $0.10 PT on MannKind (MNKD) Post Q2

MannKind Corporation Reports 2016 Second Quarter Financial Results

August 8, 2016 4:00 PM EDT

VALENCIA, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (TASE: MNKD) today reported financial results for the second quarter and the six months ended June 30, 2016.

For the second quarter ended June 30, 2016, total operating expenses were $19.1 million as compared to $24.1 million for the same quarter in 2015.  Research and development expenses were $4.3 million for the second quarter of 2016, a decrease of 44% compared to the second quarter of 2015, primarily due to a reduction in force in 2015 following the completion of Afrezza registration trials. Selling, general... More